Skip to main content
Therapeutics and Clinical Risk Management logoLink to Therapeutics and Clinical Risk Management
. 2018 Jun 26;14:1155. doi: 10.2147/TCRM.S177217

A restrictive dose of crystalloids in patients during laparoscopic cholecystectomy is safe and cost-effective: prospective, two-arm parallel, randomized controlled trial [Corrigendum]

PMCID: PMC6027822  PMID: 29983570

Belavić M, Sotošek Tokmadžić V, Brozović Krijan A, et al. Ther Clin Risk Manag. 2018;14:741–751.

In this article, the author Josip Žunić did not meet the criteria for authorship and was erroneously included in the authors list. The authors wish to apologize for this error.


Articles from Therapeutics and Clinical Risk Management are provided here courtesy of Dove Press

RESOURCES